MedinCell S.A.
MDCLFOTCHealthcare● Active
$34.39
+$0.00(+0.00%)
Market Cap$1.2B
P/E Ratio—
52W High$34.39
52W Low$6.9757
MedinCell S.A. (MDCLF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MDCLF · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2025Report Date: Dec 9, 2025EPS Actual
-$0.57
Est. -$0.31 · -85.7%
Revenue
$0.01B
Est. $0.01B · +147.0%
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Dec 9, 2025
After Market Close
▼ Miss EPS▲ Beat Revenue
MDCLF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 16, 2026 | -$0.02 | — | — | — | $0.02B | — |
| ▼ Q4 FY2025 | Dec 9, 2025 | -$0.31 | -$0.57 | -85.7% | $0.01B | $0.01B | +147.0% |
| ▲ Q2 FY2025 | Jun 17, 2025 | -$0.45 | -$0.13 | +70.7% | $0.02B | $0.01B | +201.1% |
| — Q4 FY2024 | Dec 3, 2024 | — | -$0.55 | — | $0.01B | $0.00B | +123.6% |
| — Q2 FY2024 | Jun 25, 2024 | — | -$0.63 | — | $0.00B | $0.01B | -64.3% |
| — Q4 FY2023 | Dec 21, 2023 | — | -$0.31 | — | $0.01B | — | — |
| — Q1 FY2023 | Mar 31, 2023 | — | -$0.79 | — | $0.00B | — | — |
| — Q3 FY2022 | Sep 30, 2022 | — | -$0.53 | — | $0.01B | — | — |
Q2 FY2026
Jun 16, 2026
EPS Actual
—
EPS Est.
-$0.02
EPS Surpr.
—
Revenue
—
Q4 FY2025
Dec 9, 2025Miss
EPS Actual
-$0.57
EPS Est.
-$0.31
EPS Surpr.
-85.7%
Revenue
$0.01B
Q2 FY2025
Jun 17, 2025Beat
EPS Actual
-$0.13
EPS Est.
-$0.45
EPS Surpr.
+70.7%
Revenue
$0.02B
Q4 FY2024
Dec 3, 2024
EPS Actual
-$0.55
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2024
Jun 25, 2024
EPS Actual
-$0.63
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2023
Dec 21, 2023
EPS Actual
-$0.31
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2023
Mar 31, 2023
EPS Actual
-$0.79
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Sep 30, 2022
EPS Actual
-$0.53
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2025 | Dec 9, 2025 | -85.7% | $6.98 | $6.98 | +0.00% |
| ▲ Q2 FY2025 | Jun 17, 2025 | +70.7% | $6.98 | $6.98 | +0.00% |
| — Q4 FY2024 | Dec 3, 2024 | — | $6.98 | $6.98 | +0.00% |
| — Q2 FY2024 | Jun 25, 2024 | — | $6.98 | $6.98 | +0.00% |
| — Q4 FY2023 | Dec 21, 2023 | — | $6.98 | $6.98 | +0.00% |
| — Q1 FY2023 | Mar 31, 2023 | — | $9.70 | $9.70 | +0.00% |
| — Q3 FY2022 | Sep 30, 2022 | — | $9.70 | $9.70 | +0.00% |
| — Q1 FY2022 | Mar 31, 2022 | — | $9.70 | $9.70 | +0.00% |
Q4 FY2025+0.00%
Report Date
Dec 9, 2025
EPS Beat/Miss
-85.7%
Price Before
$6.98
Price After
$6.98
Q2 FY2025+0.00%
Report Date
Jun 17, 2025
EPS Beat/Miss
+70.7%
Price Before
$6.98
Price After
$6.98
Q4 FY2024+0.00%
Report Date
Dec 3, 2024
EPS Beat/Miss
—
Price Before
$6.98
Price After
$6.98
Q2 FY2024+0.00%
Report Date
Jun 25, 2024
EPS Beat/Miss
—
Price Before
$6.98
Price After
$6.98
Q4 FY2023+0.00%
Report Date
Dec 21, 2023
EPS Beat/Miss
—
Price Before
$6.98
Price After
$6.98
Q1 FY2023+0.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$9.70
Price After
$9.70
Q3 FY2022+0.00%
Report Date
Sep 30, 2022
EPS Beat/Miss
—
Price Before
$9.70
Price After
$9.70
Q1 FY2022+0.00%
Report Date
Mar 31, 2022
EPS Beat/Miss
—
Price Before
$9.70
Price After
$9.70
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate1 / 8 quarters
Largest Move+0.00% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MDCLF ends December
MedinCell S.A. (MDCLF) most recently reported earnings on December 9, 2025 for Q4 FY2025, posting EPS of $-0.57 — missing the analyst consensus of $-0.31 by -85.7%. The next MDCLF earnings date is expected around September 1, 2026.
Each quarter, investors track MDCLF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MDCLF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MDCLF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MDCLF earnings · 5 questionsMedinCell S.A.'s next earnings report is expected around September 1, 2026. MDCLF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MDCLF historically reports after market close (AMC).
MDCLF earnings datewhen is MDCLF earningsMDCLF next earnings datewhen does MDCLF report earningsMDCLF earnings calendar
▸ Source: FMP · MedinCell S.A. SEC filings · US GAAP · MedinCell S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026